ORCID as entered in ROS

Select Publications
2017, 'Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update', Pathology, 49, pp. 346 - 355, http://dx.doi.org/10.1016/j.pathol.2017.02.005
,2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016
,2016, 'Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma', Journal of Hematology and Oncology, 9, http://dx.doi.org/10.1186/s13045-016-0278-x
,2013, 'Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer', Internal Medicine Journal, 43, pp. 424 - 429, http://dx.doi.org/10.1111/j.1445-5994.2012.02846.x
,2013, 'Using scenarios to explain life expectancy in advanced cancer: Attitudes of people with a cancer experience', Supportive Care in Cancer, 21, pp. 369 - 376, http://dx.doi.org/10.1007/s00520-012-1526-4
,2012, 'Using scenarios to explain survival time: Attitudes of people with a cancer experience.', Journal of Clinical Oncology, 30, pp. 9126 - 9126, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9126
,2022, 'An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study', in CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, CIG MEDIA GROUP, LP, pp. S29 - S30
,2011, 'Patients' Views about How Oncologists Should Explain Prognosis in Advanced Cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/0008-5472.SABCS11-P5-15-02
,2024, 'Cardiac magnetic resonance imaging for the early diagnosis of AL cardiomyopathy: a case series', MN, Rochester, Vol. 31, pp. S182 - S182, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024
,2024, 'Cardiac transplantation for transthyretin amyloidosis (ATTR): a single centre experience', MN, Rochester, Vol. 31, pp. S183 - S183, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024
,2024, 'Diagnosing transthyretin amyloidosis: a single centre experience with histopathological diagnosis', MN, Rochester, Vol. 31, pp. S238 - S238, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024
,2024, 'The prevalence of frailty and association with disease severity in transthyretin amyloid cardiomyopathy', MN, Rochester, Vol. 31, pp. S106 - S106, presented at 19th International Symposium on Amyloidosis (ISA), MN, Rochester, 26 May 2024 - 30 May 2024
,2024, 'A minority of women of childbearing potential are tested for pregnancy before chemoimmunotherapy: an Australian cancer centre experience', in Internal Medicine Journal, Vol. 54, pp. 750 - 754, http://dx.doi.org/10.1111/imj.16287
,2023, 'P-070 Failure to clear circulating tumor cells after one week of daratumumab, bortezomib and dexamethasone is associated with a reduced progression-free survival for myeloma patients', in Clinical Lymphoma Myeloma and Leukemia, Elsevier BV, Vol. 23, pp. S73 - S73, http://dx.doi.org/10.1016/s2152-2650(23)01688-9
,2023, 'Single-Cell Ligand-Receptor Analysis Identifies Dormant Tumour Cell Control Pathways in the Skeleton', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY, Vol. 38, pp. 55 - 55
,2022, 'Rate of menstruation history taking and counselling before, during and after anticancer treatments', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 174 - 175
,2022, 'Rates of contraceptive uptake and documentation of discussion with anticancer therapy: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 209 - 209
,2022, 'Rates of fertility discussions and counselling before, during and after anticancer treatments: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 175
,2022, 'Rates of sexual history taking and sexual dysfunction counselling with cancer care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 176
,2022, 'Role of Endomyocardial Biopsy and Mass Spectrometry for Precision in Cardiac Amyloid Subtyping: A Case Series', in Heart, Lung and Circulation, Elsevier BV, Vol. 31, pp. S99 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.123
,2021, 'A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 39, presented at Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 04 June 2021 - 08 June 2021, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS8055
,2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', in BLOOD, AMER SOC HEMATOLOGY, Vol. 136, http://dx.doi.org/10.1182/blood-2020-138991
,2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', in Blood, American Society of Hematology, Vol. 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269
,